Combination of Anti–Programmed Death 1 Therapy and Apatinib for a Patient with Hepatocellular Carcinoma and Brain Metastasis: Case Report and Literature Review
- 10 June 2020
- journal article
- case report
- Published by Elsevier in World Neurosurgery
- Vol. 143, 114-117
- https://doi.org/10.1016/j.wneu.2020.06.015
Abstract
No abstract availableKeywords
Funding Information
- Beijing Municipal Administration of Hospitals (ZYLX201608)
This publication has 23 references indexed in Scilit:
- Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinomaJournal of Neuro-Oncology, 2014
- Brain metastases from hepatocellular carcinoma: clinical features and prognostic factorsBMC Cancer, 2012
- Hepatocellular CarcinomaAnnals of Surgery, 2011
- Little Response of Cerebral Metastasis from Hepatocellular Carcinoma to Any TreatmentsJournal of Korean Neurosurgical Society, 2010
- Efficacy of surgical resection in management of isolatedextrahepatic metastases of hepatocellular carcinomaWorld Journal of Gastroenterology, 2009
- Brain metastases from hepatocellular carcinoma: prognostic factors and outcomeJournal of Neuro-Oncology, 2008
- Brain Metastases from Hepatocellular Carcinoma in US PatientsJournal of Neuro-Oncology, 2006
- Clinical features of hepatocellular carcinoma with extrahepatic metastasesJournal of Gastroenterology and Hepatology, 2005
- Intracranial metastasis of hepatocellular carcinoma: review of 45 casesSurgical Neurology, 2004
- Intracranial metastases of hepatocellular carcinoma: CT and MRINeuroradiology, 1996